No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs550653732 |
chr17:16395117-16395118 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs569944240 |
chr17:16395134-16395135 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs538927430 |
chr17:16395194-16395195 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Weak transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs552449211 |
chr17:16395238-16395239 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Enhancers
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs113989349 |
chr17:16395337-16395338 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs565860556 |
chr17:16395512-16395513 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs534746682 |
chr17:16395577-16395578 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs554723238 |
chr17:16395589-16395590 |
Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs574400682 |
chr17:16395617-16395618 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs537057637 |
chr17:16395623-16395624 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs556671795 |
chr17:16395642-16395643 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs577510806 |
chr17:16395680-16395681 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs546065582 |
chr17:16395753-16395754 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs559553825 |
chr17:16395754-16395755 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs573116875 |
chr17:16395765-16395766 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs118095564 |
chr17:16395801-16395802 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs115237542 |
chr17:16395808-16395809 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs9916648 |
chr17:16395937-16395938 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs60357719 |
chr17:16395946-16395947 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs550995218 |
chr17:16395954-16395955 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs1007259 |
chr17:16395979-16395980 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
22 |
rs7342950 |
chr17:16395997-16395998 |
Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs139733170 |
chr17:16396017-16396018 |
Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs552487849 |
chr17:16396087-16396088 |
Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs79657574 |
chr17:16396088-16396089 |
Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs34410887 |
chr17:16396110-16396111 |
Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs35281662 |
chr17:16396138-16396139 |
Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs371808959 |
chr17:16396139-16396140 |
Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs202171040 |
chr17:16396143-16396144 |
Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs76836925 |
chr17:16396183-16396184 |
Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs553232743 |
chr17:16396186-16396187 |
Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs568186088 |
chr17:16396199-16396200 |
Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs536742216 |
chr17:16396248-16396249 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs368916971 |
chr17:16396303-16396304 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs556944226 |
chr17:16396331-16396332 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs576746755 |
chr17:16396341-16396342 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs8079803 |
chr17:16396387-16396388 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
38 |
rs553272644 |
chr17:16396456-16396457 |
Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs573154090 |
chr17:16396465-16396466 |
Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs139773188 |
chr17:16396481-16396482 |
Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs184684869 |
chr17:16396497-16396498 |
Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs371496208 |
chr17:16396538-16396539 |
Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
TF binding regionCpG islandChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs76526780 |
chr17:16396566-16396567 |
Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs144487163 |
chr17:16396569-16396570 |
Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs572938431 |
chr17:16396624-16396625 |
Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs75804206 |
chr17:16396662-16396663 |
Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs566643991 |
chr17:16396682-16396683 |
Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs544359104 |
chr17:16396713-16396714 |
Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs564541811 |
chr17:16396823-16396824 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs59062761 |
chr17:16396855-16396856 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|